About: covid:PMC7123735

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7123735 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Thompson, John Atkins, Michael Farma, Jeffrey Gershenwald, Jeffrey Miura, John Tanabe, Kenneth Balch, Charles Ariyan, Charlotte Garbe, Claus Halpern, Allan Kirkwood, John McArthur, Grant Mutabdzic, Dorotea Perez, Matthew Sober, Arthur Zager, Jonathan
topic	covid:PMC7123735#this
is http://vocab.deri.ie/void#inDataset of	https://covidontheweb.inria.fr:4443/about/id/http/ns.inria.fr/covid19/PMC7123735
is schema:about of	named entity 'Melanoma' named entity 'urine' named entity 'bleomycin' named entity 'Anesthesia' named entity 'vascularization' named entity 'toxicity' named entity 'primary tumors' named entity 'tumor' named entity 'tourniquet' named entity 'toxicity' named entity 'BCG' named entity 'lymphadenectomy' named entity 'malignant melanoma' named entity 'toxicity' named entity 'long-lasting' named entity 'amputation' named entity 'lymphadenectomy' named entity 'melanomas' named entity 'necrotic cell death' named entity 'operating room' named entity 'BCG' named entity '12 weeks' named entity 'metastatic melanoma' named entity 'MEK inhibitor' named entity 'melphalan' named entity 'complete response' named entity 'melanoma' named entity 'colloid' named entity 'WHO' named entity 'TNFα' named entity 'tumors' named entity 'protamine' named entity 'tumors' named entity 'atherosclerotic plaque' named entity 'survival rates' named entity 'neoadjuvant' named entity 'FDA' named entity 'lymphadenectomy' named entity 'T-VEC' named entity 'complete response' named entity 'treatment modality' named entity 'PD1' named entity 'perfusion' named entity 'immunotherapy' named entity 'Talimogene laherparepvec' named entity 'palliative' named entity 'proximal and distal' named entity 'recombinant fusion proteins' named entity 'metastatic cancers' named entity 'toxicity' named entity 'ILI' named entity 'dacarbazine' named entity 'desflurane' named entity 'lower extremity' named entity 'decay-accelerating factor' named entity 'neoadjuvant' named entity 'general anesthesia' named entity 'normothermic' named entity 'Mycobacterium bovis' named entity 'BRAF' named entity 'serum' named entity 'Perfusion' named entity 'MSLT' named entity 'TNFα' named entity 'melphalan' named entity 'hemorrhagic' named entity 'minimally-invasive' named entity 'erythema' named entity 'aorta' named entity 'intravenously' named entity 'tourniquet' named entity 'neoadjuvant' named entity 'granulocytes' named entity 'antigen presentation' named entity 'live, attenuated' named entity 'immunotherapy' named entity 'venous return' named entity '12 weeks' named entity 'PD1' named entity 'statistically significant' named entity 'objective response rate' named entity '13.8'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software